In this editor’s desk, Rebekah Jordan shares her views on the achievements within pharma sustainability in 2022, its criticality in pharma investment opportunities, and what’s still to be done.
In this editor’s desk, Rebekah Jordan shares her views on the achievements within pharma sustainability in 2022, its criticality in pharma investment opportunities, and what’s still to be done.
